Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression

Journal of Virology

Volumn 84, Issue 4, 2010, Pages 2063-2077

  Segundo, Fayna Diaz San ^a,b   Moraes, Mauro P ^a   De Los Santos, Teresa ^a   Dias, Camila C A ^a,b   Grubman, Marvin J ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ADENOVIRUS VECTOR; ALPHA INTERFERON; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDOLEAMINE 2,3 DIOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN MX1; UNCLASSIFIED DRUG;

ADENOVIRUS 5; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; DENDRITIC CELL; FOOT AND MOUTH DISEASE VIRUS; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INNATE IMMUNITY; INOCULATION; LYMPH NODE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SKIN; SWINE; UPREGULATION; VIREMIA; VIRUS INFECTION;

ADENOVIRUSES, HUMAN; ANIMALS; CYTOKINES; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENE EXPRESSION; GENETIC VECTORS; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INTERFERON TYPE I, RECOMBINANT; INTERFERON-GAMMA, RECOMBINANT; KILLER CELLS, NATURAL; LANGERHANS CELLS; MALE; SUS SCROFA; SWINE; SWINE DISEASES; VIREMIA;

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; HUMAN ADENOVIRUS TYPE 5; SUIDAE;

EID: 75449092280     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01874-09     Document Type: Article

References (62)

1. Ahmad, A., E. Sharif-Askari, L. Fawaz, and J. Menezes. 2000. Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction. J. Virol. 74:7196-7203.
2. Akira, S. 2000. The role of IL-18 in innate immunity. Curr. Opin. Immunol. 12:59-63.
3. Alexandersen, S., Z. Zhang, A. I. Donaldson, and A. J. Garland. 2003. The pathogenesis and diagnosis of foot-and-mouth disease. J. Comp. Pathol. 129:1-36.
4. Andoniou, C. E., S. L. H. van Dommelen, V. Voigt, D. M. Andrews, G. Brizard, C. Asselin-Paturel, T. Delale, K. J. Stacey, G. Trinchieri, and M. A. Degli-Esposti. 2005. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nature Immunol. 214:331-341.
5. Basler, C. F., and A. Garcia-Sastre. 2002. Viruses and the type I interferon antiviral system: induction and evasion. Int. Rev. Immunol. 21:305-337.
6. Bautista, E. M., D. Gregg, and W. T. Golde. 2002. Characterization and functional analysis of skin-derived dendritic cells from swine without a requirement for in vitro propagation. Vet. Immunol. Immunopathol. 88:131-148.
7. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189-220.
8. Brown, Z., M. E. Gerritsen, W. W. Carley, R. M. Strieter, S. L. Kunkel, and J. Westwick. 1994. Chemokine gene expression and secretion by cytokineactivated human microvascular endothelial cells. Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma. Am. J. Pathol. 145:913-921.
9. Caberg, J. H., P. Hubert, L. Herman, M. Herfs, P. Roncarati, J. Boniver, and P. Delvenne. 2008. Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20. Cancer Immunol. Immunother. 58:39-47.
10. Charbonnier, A. S., N. Kohrgruber, E. Kriehuber, G. Stingl, A. Rot, and D. Maurer. 1999. Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal Langerhans cells. J. Exp. Med. 190: 1755-1768.
11. Chen, J. P., H. L. Lu, S. L. Lai, G. S. Campanella, J. M. Sung, M. Y. Lu, B. A. Wu-Hsieh, Y.-L. Lin, T. E. Lane, A. D. Luster, and F. Liao. 2006. Dengue virus induces expression of CXC chemokine ligand 10/IFN-γ-inducible protein 10, which competitively inhibits viral binding to cell surface heparin sulfate. J. Immunol. 177:3185-3192.
12. Chinsangaram, J., M. Koster, and M. J. Grubman. 2001. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol. 75:5498-5503.
13. Chinsangaram, J., M. P. Moraes, M. Koster, and M. J. Grubman. 2003. Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. J. Virol. 77:1621-1625.
14. Chinsangaram, J., M. E. Piccone, and M. J. Grubman. 1999. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J. Virol. 73:9891-9898.
15. Della Chiesa, M., S. Sivori, R. Castriconi, E. Marcenaro, and A. Moretta. 2005. Pathogen-induced private conversations between natural killer and dendritic cells. Trends Microbiol. 13:128-136.
16. de los Santos, T., S. de Avila Botton, R. Weiblen, and M. J. Grubman. 2006. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 80:1906-1914.
17. Der, S. D., A. Zhou, B. R. G. Williams, and R. H. Silverman. 1998. Identi-fication of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc. Natl. Acad. Sci. U. S. A. 95:15623-15628.
18. Diaz-San Segundo, F., T. Rodriguez-Calvo, A. de Avila, and N. Sevilla. 2009. Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10. PLoS One 4:1-11.
19. Díaz-San Segundo, F., F. J. Salguero, A. de Avila, M. M. de Marco, M. A. Sanchez-Martín, and N. Sevilla. 2006. Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J. Virol. 80:2369-2379.
20. Fantuzzi, L., P. Puddu, B. Varano, M. Del Cornò, F. Belardelli, and S. Gessani. 2000. IFN-alpha and IL-18 exert opposite regulatory effects on the IL-12 receptor expression and IL-12-induced IFN-gamma production in mouse macrophages: novel pathways in the regulation of the inflammatory response of macrophages. J. Leukoc. Biol. 68:707-714.
21. Fehniger, T. A., M. A. Cooper, G. J. Nuovo, M. Cella, F. Facchetti, M. Colonna, and M. A. Caligiuri. 2003. CD56bright natural killer cells are present in human lymph nodes and are activated by T-cell derived IL-2: a potential new link between adaptive and innate immunity. Blood 101:3052-3057.
22. Ferlazzo, G., D. Thomas, S. L. Lin, K. Goodman, B. Morandi, W. A. Muller, A. Moretta, and D. Munz. 2004. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172:1455-1462.
23. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
24. Fujita, H., A. Asahina, Y. Tada, H. Fujiwara, and K. Tamaki. 2005. Type I interferons inhibit maturation and activation of mouse Langerhans cells. J. Invest. Dermatol. 125:126-133.
25. Golde, W. T., J. M. Pacheco, H. Duque, T. Doel, B. Penfold, G. S. Ferman, D. R. Gregg, and L. L. Rodriguez. 2005. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response. Vaccine 23:5775-5782.
26. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus 5. J. Gen. Virol. 36:59-72.
27. Granucci, F., I. Zanoni, N. Pavelka, S. L. Van Dommelen, C. E. Andoniou, F. Belardelli, M. A. Degli Esposti, and P. Ricciardi-Castagnoli. 2004. A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J. Exp. Med. 200:287-295.
28. Grubman, M. J., and B. Baxt. 2004. Foot-and-mouth disease. Clin. Microbiol. Rev. 17:465-493.
29. Henke, A., R. Zell, G. Ehrlich, and A. Stelzner. 2001. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis. J. Virol. 75:8187-8194.
30. Jung, K., and C. Chae. 2006. Expression of Mx protein and interferon-a in pigs experimentally infected with swine influenza virus. Vet. Pathol. 43:161-167.
31. Kasama, T., R. M. Strieter, T. J. Standiford, M. D. Burdick, and S. L. Kunkel. 1993. Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha. J. Exp. Med. 178:63-72.
32. Lindell, D. M., T. E. Lane, and N. W. Lukacs. 2008. CXCL10/CXCR3-mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8 T-cell efficiency. Eur. J. Immunol. 38:2168-2179.
33. Longhi, M. P., C. Trumpfheller, J. Idoyaga, M. Caskey, I. Matos, C. Kluger, A. M. Salazar, M. Colonna, and R. M. Steinman. 2009. Dendritic cells require a systemic type I interferon response to mature and induce CD4 Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206:1589-1602.
34. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Natural killer cell-mediated control of infections requires production of interleukin 15 by type I IFN-triggered dendritic cells. Immunity 26:503-517.
35. Luster, A. D., J. C. Unkeless, and J. V. Ravetch. 1985. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315:672-676.
36. Moraes, M. P., J. Chinsangaram, M. C. S. Brum, and M. J. Grubman. 2003. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 22:268-279.
37. Moraes, M. P., T. de los Santos, M. Koster, T. Turecek, H. Wang, V. G. Andreyev, and M. J. Grubman. 2007. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J. Virol. 81:7124-7135.
38. Moraes, M. P., G. A. Mayr, P. W. Mason, and M. J. Grubman. 2002. Early protection against homologous challenge after a single dose of replicationdefective human adenovirus type 5 expressing capsid proteins of foot-andmouth disease virus (FMDV) strain A24. Vaccine 20:1631-1639.
39. Muruve, D. A., M. J. Barnes, I. E. Stillman, and T. A. Libermann. 1999. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum. Gene Ther. 10:965-976.
40. Musikacharoen, T., A. Oguma, Y. Yoshikai, N. Chiba, A. Masuda, and T. Matsuguchi. 2005. Interleukin-15 induces IL-12 receptor β1 gene expression through PU. 1 and IRF 3 by targeting chromatin remodeling. Blood 105: 711-720.
41. Nfon, C. K., H. Dawson, F. N. Toka, and W. T. Golde. 2008. Langerhans cells in porcine skin. Vet. Immunol. Immunopathol. 126:236-247.
42. Okuse, C., J. A. Rinaudo, K. Farrar, F. Wells, and B. E. Korba. 2005. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy. Antivir. Res. 65:23-34.
43. Orange, J. S., and C. A. Biron. 1996. Characterization of early IL-12, IFN-α/β, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746-4756.
44. Pacheco, J. M., M. C. S. Brum, M. P. Moraes, W. T. Golde, and M. J. Grubman. 2005. Rapid protection of cattle from direct challenge with footand-mouth disease virus (FMDV) by a single inoculation with an adenovirus vectored FMDV subunit vaccine. Virology 337:205-209.
45. Pena, L., M. P. Moraes, M. Koster, T. Burrage, J. M. Pacheco, F. Diaz-San Segundo, and M. J. Grubman. 2008. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine. Vaccine 26:5689-5699.
46. Pintaric, M., W. Gerner, and A. Saalmuller. 2008. Synergistic effects of IL-2, Il-12 and IL-18 on cytolytic activity, perforin expression and IFN-γ production of porcine natural killer cells. Vet. Immunol. Immunopathol. 121:68-82.
47. Raymond, C. R., and B. N. Wilkie. 2005. Toll-like receptor, MHC II, B7 and cytokine expression by porcine monocytes and monocyte-derived dendritic cells in response to microbial pathogen-associated molecular patterns. Vet. Immunol. Immunopathol. 107:235-247.
48. Salazar-Mather, T. P., and K. L. Hokeness. 2006. Cytokine and chemokine networks: pathways to antiviral defense. Curr. Top. Microbiol. Immunol. 303:29-46.
49. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.
50. Scapini, P., C. Laudanna, C. Pinardi, P. Allavena, A. Mantovani, S. Sozzani, and M. A. Cassatella. 2002. Neutrophils produce biologically active macrophage inflammatory protein-3α (MIP-3α)/CCL20 and MIP-3β/CCL19. Eur. J. Immunol. 31:1981-1988.
51. Summerfield, A., and K. C. McCullough. 2009. The porcine dendritic cell family. Dev. Comp. Immunol. 33:299-309.
52. Takaoka, A., and H. Yanai. 2006. Interferon signalling network in innate defense. Cell Microbiol. 8:907-922.
53. Tan, H., J. Derrick, J. Hong, C. Sanda, W. M. Grosse, H. J. Edenberg, M. Taylor, S. Seiwert, and L. M. Blatt. 2005. Global transcriptional profiling demonstrates the combination of type I and type II interferon enhances antiviral and immune responses at clinically relevant doses. J. Interferon Cytokine Res. 25:632-649.
54. Taub, D. D., T. J. Sayers, C. R. D. Carter, and J. R. Ortaldo. 1995. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:3877-3888.
55. Tebo, J. M., H. S. Kim, J. Gao, D. A. Armstrong, and T. A. Hamilton. 2009. Interleukin-10 suppresses IP-10 gene transcription by inhibiting the production of class I interferon. Blood 92:4742-4749.
56. Tilg, H. 1997. New insights into the mechanisms of interferon alpha: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology 112: 1017-1021.
57. Toka, F. N., C. K. Nfon, H. Dawson, and W. T. Golde. 2009. Accessory-cellmediated activation of porcine NK cells by Toll-like receptor 7 (TLR7) and TLR8 agonists. Clin. Vaccine Immunol. 16:866-878.
58. Trifilo, M. J., C. Montalto-Morrison, L. N. Stiles, K. R. Hurst, J. L. Hardison, J. E. Manning, P. S. Masters, and T. E. Lane. 2004. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. J. Virol. 78:585-594.
59. Tsunoda, I., T. E. Lane, J. Blackett, and R. S. Fujinami. 2004. Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10. Multiple Sclerosis 10:26-34.
60. Wu, Q., M. C. S. Brum, L. Caron, M. Koster, and M. J. Grubman. 2003. Adenovirus-mediated type I interferon expression partially protects cattle from foot-and-mouth disease. J. Interferon Cytokine Res. 23:371-380.
61. Yang, H., and M. E. Parkhouse. 1996. Phetotypic classification of porcine lymphocyte subpopulations in blood and lymphoid tissues. Immunology 89: 76-83.
62. Yuan, J., Z. Liu, T. Lim, H. Zhang, J. He, E. Walker, C. Shier, Y. Wang, Y. Su, A. Sall, B. McManus, and D. Yang. 2009. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis. Circ. Res. 104:628-638.